-
Chemo or Not?Tumor profiling tests that predict the likelihood of distant recurrence can help some women with early-stage, hormone receptor-positive breast cancer decide on treatments after surgery.
by Kris Conner
-
Forward Look
Black Patients Less Likely to Receive Targeted RadiationStudy finds racial disparities in the use of proton beam therapy, a focused treatment that can reduce side effects.
by Carolyn Bernhardt
-
Forward Look
Targeting Cancer in KidsNew studies probe how to match targeted therapies to children with cancer.
by Stephen Ornes
-
Forward Look
What’s NextA magnet-guided robot could help doctors look for signs of cancer deeper in the passages of the lungs.
by Darcy Lewis
-
Forward Look
Be Clear About Treatment GoalsPeople with late-stage cancer must ask what they want from treatment.
by Tyler Santora
-
Forward Look
Women, Men and Treatment Side EffectsStudy shows women have a higher risk of side effects from immunotherapy, adding to evidence that men and women react differently to treatment.
by Delia O'Hara
-
From the Editor-in-Chief
Cancer and AgingCancer cells exploit an aging "infrastructure" to threaten life in those 60 and older.
by William G. Nelson, MD, PhD
-
Cultural Competence in the CommunityResearchers describe their efforts to understand and improve cancer screening and treatment among underserved populations.
by Kevin McLaughlin
-
Working Toward the End of Cancer Health DisparitiesAACR conference explores the science of cancer disparities and what needs to be done to improve cancer outcomes for all people.
by Eric Fitzsimmons
-
Taking Stock of CAR T-Cell TherapyFive years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.
by Kendall K. Morgan
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
